Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1

This study has been terminated.
(slow accrual)
Sponsor:
Collaborators:
Genentech
Novartis
Information provided by (Responsible Party):
Sandy Srinivas, Stanford University
ClinicalTrials.gov Identifier:
NCT00651482
First received: March 28, 2008
Last updated: January 25, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)